Fourrts (India) Laboratories Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
- Paid Up Capital ₹ 62.94 Cr
- Company Age 45 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 327.64 Cr
- Satisfied Charges ₹ 107.44 Cr
- Revenue Growth 12.15%
- Profit Growth -23.84%
- Ebitda -9.46%
- Net Worth 11.89%
- Total Assets 13.25%
About Fourrts (India) Laboratories
Fourrts (India) Laboratories Private Limited (FILPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 March 1979 and has a history of 45 years and ten months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Corporate was formerly known as Fourts (India) Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 62.94 Cr.
The company currently has active open charges totaling ₹327.64 Cr. The company has closed loans amounting to ₹107.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Fourrts (India) Laboratories Private Limited India is Rathinasamy Ashokkumar as COMPANY SECRETARY. Sekharipuram Veeramani, Veerramani Radha, Mohan Iyer, and Three other members serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85185TN1979PTC007782
- Company No.
007782
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 1979
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Fourrts (India) Laboratories Private Limited offer?
Fourrts (India) Laboratories Private Limited offers a wide range of products and services, including Pain Killers, Forte Tablets, Anti Cancer Medicines, Glivec Tablets, Business Consultant, Business Solution, Mineral Supplement, Concentrated Mineral Drop, Tax Consultancy Service, Taxation Service.
Who are the key members and board of directors at Fourrts (India) Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sekharipuram Veeramani  | Managing Director | 31-Mar-1979 | Current |
| Rathinasamy Ashokkumar | Company Secretary | 10-Apr-2024 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veerramani Radha | Director | 31-Oct-1991 | Current |
| Mohan Iyer | Additional Director | 15-Dec-2021 | Current |
| Nitia Mohan | Additional Director | 15-Dec-2021 | Current |
Gayatri Jayaraman  | Additional Director | 15-Dec-2021 | Current |
| Sundar Jayaraman | Additional Director | 15-Dec-2021 | Current |
Financial Performance of Fourrts (India) Laboratories.
Fourrts (India) Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.15% increase. The company also saw a substantial fall in profitability, with a 23.84% decrease in profit. The company's net worth Soared by an impressive increase of 11.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fourrts (India) Laboratories?
In 2023, Fourrts (India) Laboratories had a promoter holding of 82.66% and a public holding of 17.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharmaceuticals Export Promotion Council Of IndiaSekharipuram Veeramani is a mutual person
Charges (Loans)
₹327.64 Cr
₹107.44 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 176.80 Cr
- Sbicap Trustee Company Limited : 149.00 Cr
- Others : 0.69 Cr
- Bank Of India : 0.60 Cr
- The Tamilnadu Industrial Investmant Coroporation Imited : 0.20 Cr
- Others : 0.36 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2024 | Others | ₹6.89 M | Open |
| 30 May 2022 | Bank Of India | ₹6.00 M | Open |
| 17 Nov 2021 | Axis Bank Limited | ₹17.80 Cr | Open |
| 28 Jun 2021 | Sbicap Trustee Company Limited | ₹149.00 Cr | Open |
| 12 Jan 2021 | Axis Bank Limited | ₹10.00 Cr | Open |
How Many Employees Work at Fourrts (India) Laboratories?
Fourrts (India) Laboratories has a workforce of 2603 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fourrts (India) Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fourrts (India) Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
